DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio

Wednesday, 15 June 2016

Shankar Hariharan


Shankar Hariharan

Chief Scientific Officer/EVP - Specialty Pharmaceuticals and Global R&D at Amneal Pharmaceuticals
 email shankarh@aol.com


Executive Vice President & Chief Scientific Officer

Shankar Hariharan, PhD

Dr. Hariharan oversees Research  & Development, Regulatory Affairs and Specialty Pharmaceutical Dosage Development. He has 30 years of experience in successfully leading branded and generic businesses and held leadership roles at International Development Research, Forest Labs and Par Pharmaceuticals. Prior to joining 

Amneal, he founded his own pharmaceutical R&D organization, DermAct, specializing in dermatology. Dr. Hariharan completed his bachelor’s degree in pharmacy at Banaras Hindu University in India and his doctorate in pharmacy at Northeastern University in Boston, Massachusetts.


President and CEO

DermAct Pharmaceutical Inc.
 –  (3 years 5 months)
Anti-angiogenesis dependent disease (anti-FGF) - product developemnt research related to topical diseses dependent on FGF
Involved in all aspects of developemnt and fundraisng for lead molecule


Par Pharmaceutical
 –  (2 years 6 months)
CSO - Head of R&D - CMC (Formulation, Analytical R&D, Biopharm), Regulatory, Clinical Development and Medical Affairs, Complaince, Quality Control/Assurance, Project Management

SVP-FRI (PR&D) and VP- Forest Labs (Corporate)

Forest Laboratories
 –  (14 years 4 months)
Head of Pharmaceutical Developemnt - all aspects of CMC
Drug Metabolism and bioanalytical Research
Project Management
Management Information System and Automation related to R&D


 –  (3 years 1 month)
Head of Bioanlaytical and Metabolism Research


Institute of Technology, BHU

Pharmaceutics -

Finished 1-1/2 years of M.Pharm - then left for Ph.D at Northestern University, Boston, MA - Jan 1982

Shankar Hariharan


No comments:

Post a Comment